Resilience to chronic stress is mediated by noradrenergic regulation of dopamine neurons. Nature Neuroscience, Frebruary 2016
Selective genetic disruption of dopaminergic, serotonergic and noradrenergic neurotransmission: insights into motor, emotional and addictive behaviour. Journal of Psychiatry and Neuroscience, october 2015.
Chronic nandrolone decanoate exposure during adolescence affects emotional behavior and monoaminergic neurotransmission in adulthood. Neuropharmacology, august 2014.
Anxiolytic effects of the melatonin MT(2) receptor partial agonist UCM765: comparison with melatonin and diazepam. Prog Neuropsychopharmacol Biol Psychiatry, december 2012.
Differential environmental regulation of neurogenesis along the septo-temporal axis of the hippocampus. Neuropharmacology, september 2012.
Ventral hippocampal molecular pathways and impaired neurogenesis associated with 5-HT₁A and 5-HT₁B receptors disruption in mice. Neuroscience Letter, july 2012.
Beneficial behavioural and neurogenic effects of agomelatine in a model of depression/anxiety. International Journal of Neuropsychopharmacology, april 2012.
Functional status of somatodendritic serotonin 1A autoreceptor after long-term treatment with fluoxetine in a mouse model of anxiety/depression based on repeated corticosterone administration. Molecular Phamacology, february 2012.
Antidepressants recruit new neurons to improve stress response regulation. Molecular Psychiatry, december 2011.
Characterization of 5-HT(1A/1B)-/- mice: an animal model sensitive to anxiolytic treatments. Neuropharmacology, september 2011.
Implications of the functional integration of adult-born hippocampal neurons in anxiety-depression disorders. Neuroscientist, october 2010.
Neurogenesis-dependent and independent effects of anti-depressant drugs. Medecine & Science, october 2009.
Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron, may 2009.
Role of hippocampal neurogenesis in the mechanism of action of antidepressant/anxiolytic drugs in animal model of depression and anxiety. Neurobiology of Mood Disorders, september 2013.
Involvement of hippocampal neurogenesis in the control of the HPA axis: evidence from animal models of affective disease. European Neuropsychopharmacology, september 2010.
Reconcile the neurogenesis and the HPA axis hypothesis of depression and of antidepressant action. Behavioural Pharmacology, august 2011.
Role of hippocampal neurogenesis in the pathophysiology and treatment of depression. Neurobiology of Mood Disorders, september 2013.
Mes compétences :
Test comportementaux chez le rongeur